Gastroenterology Research and Practice / 2012 / Article / Tab 2

Clinical Study

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Table 2

Toxicities observed in ten patients treated with adjuvant intraperitoneal pemetrexed combined with intravenous cisplatin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.

Grade I-IIGrade III-IV

Abdominal pain50
Catheter infection01

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.